Managing and optimizing chemical screening for contraceptive drug development
CHEMICAL SCREENING AND OPTIMIZATION FACILITY - MANAGEMENT, ADMINISTRATION AND DATABASE CORE FUNCTION ACTIVITIES
This study is all about improving contraceptive methods and treatments for reproductive health issues, like infertility and gynecologic pain, by organizing and managing a special facility that tests new chemical compounds.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project ID | NIH-11179086 on NIH RePORTER |
What this research studies
This research focuses on the management and administration of a facility dedicated to chemical screening and optimization, which supports the development of contraceptive drugs. It involves the organization of chemical and biological inventories, maintenance of equipment, and management of data related to various reproductive health conditions. The facility aims to identify and optimize small molecules that can serve as contraceptives or treatments for reproductive health issues, including infertility and gynecologic pain. Patients may benefit from advancements in contraceptive methods and treatments for related health conditions.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals experiencing infertility, dysmenorrhea, or other reproductive health challenges.
Not a fit: Patients not experiencing reproductive health issues or those not seeking contraceptive options may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved contraceptive options and treatments for various reproductive health issues.
How similar studies have performed: Previous research in contraceptive drug development has shown promise, indicating that this approach may lead to significant advancements in the field.
Where this research is happening
Menlo Park, United States
- Sri International — Menlo Park, United States (Active)
Researchers
- Principal investigator: Gong, Leyi — Sri International
- Study coordinator: Gong, Leyi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.